https://patentbrief.org/company/novartis-ag Plain-English explanations of patents assigned to Novartis AG, newest first. en-us Mon, 15 Jun 2026 06:00:48 GMT https://patentbrief.org/patent/us/10472419/keytruda-pembrolizumab A patent describing specific genetic blueprints for antibodies designed to bind to and inhibit the TIM-3 protein, a key target in cancer and immune system research. Tue, 12 Nov 2019 00:00:00 GMT https://patentbrief.org/patent/us/10472419/keytruda-pembrolizumab https://patentbrief.org/patent/us/7740842/herceptin-adjuvant-therapy Novartis's patent describes a specific liquid recipe for keeping high concentrations of E25 anti-IgE antibodies stable and usable for medical injections. Tue, 22 Jun 2010 00:00:00 GMT https://patentbrief.org/patent/us/7740842/herceptin-adjuvant-therapy